Table 1—

Clinical details of stable transplant recipients

SexAge yrsOriginal diseaseDays post-transplantMaximum FEV1 %Rejection grade#BAL micro-organismsCsA level µg·L−1Pred dose mgAza dose mg
M34BR37684A1B0nil1621525
F32CF6795A0B0nil3601575
F23CF102100A0B0nil2571525
F41PPH200100A1B2CMV, SA19515125
M36CF75100A1B2PsA, ASP8202075
F34E190100A0B0CMV2641575
F35E419100A0B0nil21012.575
F42E542100A1BXnil1347.550
M22CF186100A1BXCMV4327.550
F31CF58100A1B2CMV7102050
M33E1301100A0B0SPn2657.5100
M46S146100A0B2CMV31117.525
F46BR107100A1BXSA3071550
F40BR189100A1B0nil22512.550
M20E73299A0B0nil2437.5100
M39CF54791A1B0PsA, CMV4937.550
F35PPH37692A0B0nil3797.5100
M54Em54599A1B1SMalt2761550
F58BR189100A0B0CMV1691550
M53Em91100A0BXCMV40517.525
M47EA8192A1BXSA373200
F22CF35798A1B2PsA, SA1077.525
M58Em173100A0B0nil2271550
F21CF29495A1B2SA405150
F58BR20094A0BXPsA20815100
F29E283100A0B0nil4921550
36 (20–58)195 (58–1301)100 (84–100)270.5 (134–82)15 (7.5–20)50 (0–125)
  • FEV1: forced expiratory volume in one second

  • M: male

  • F: female

  • BR: bronchiectasis

  • CF: cystic fibrosis

  • PPH: primary pulmonary hypertension

  • E: Eisenmengers syndrome

  • S: sarcoid

  • Em: emphysema

  • EA: extrinsic alveolitis

  • CMV: cytomegalovirus (viral IF)

  • SA: staphylococcus aureus

  • PsA: Pseudomonas aeruginosa

  • ASP: aspergillus

  • SPn: streptococ pseudomonas

  • SMalt: Stenotrophomonas Maltophilia

  • CsA: cyclosporine

  • Pred: prednisolone

  • Aza: azathioprine

  • #: acute rejection 0–4

  • B: airway inflammation 0–4 (X=ungradable)